AKT3 and cancer: Moreover, we found that the low expression of AKT3 in the exosomes of cancer tissues can lead to the reduction of CD4 + T cells and macrophage levels in the tumor microenvironment, further affecting the prognosis of CRC tumors and T, M, N, and stage, leading to accelerated cancer development and metastasis.